The IL1RL1 gene helps control how the immune system responds to tissue stress, especially in the airways and skin. This gene plays an important role in sending signals that can trigger or calm inflammation. If it does not work as expected, immune responses may become unbalanced, which can influence a person’s tendency toward asthma, allergies, eczema, and higher levels of eosinophils, a type of white blood cell. Most variants in the IL1RL1 gene are not diagnostic on their own, but some are linked to differences in allergy and asthma risk.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells can use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that carry out much of their work. Other genes are mainly involved in controlling when certain processes happen, where they happen, and how active they are. As a group, genes help shape how the body develops and works, and they can influence how you respond to food, stress, or medications. For a closer look at this topic, you can learn more in the LearnHub.
Overview
IL1RL1Gene function
What if the gene works
The IL1RL1 gene helps immune cells sense the immune signal IL-33. This supports controlled inflammation and can help the body respond to infections, allergens, and tissue stress.
Risk
What if the gene does not work
If the IL1RL1 gene works less well, cells may respond abnormally to IL-33, a signal that helps coordinate immune activity. Variants can be mild or more disruptive, so the effect on receptor signaling and cell communication can vary.
Treatment
What does that mean for your treatment
No IL1RL1-specific treatment or drug selection approach is currently established for pathogenic or loss-of-function variants in the IL1RL1 gene. The IL-33/ST2 pathway, which involves the IL1RL1 gene, is under study as a drug target in asthma and other inflammatory conditions, and soluble ST2 is used as a biomarker in heart failure care.
Gene function
What if the gene works
Your immune system uses the IL1RL1 gene to sense signals released when tissues are irritated or under strain. It is especially active in barrier areas such as the airways, skin, and gut, where your body meets the outside world. This helps explain the IL1RL1 gene’s role in the immune system and how cells coordinate a measured response and support tissue healing.
The IL1RL1 gene helps certain cells detect IL-33, a signal released by stressed or injured tissue. This lets the immune system notice local trouble and respond in a coordinated way.
After IL-33 is detected, cells use the IL1RL1 gene’s protein to pass that message inward. This switches on signals that guide immune cells to release helpful messengers and coordinate nearby cells.
This gene is active in tissues that line the body, including the airways, skin, and gut. It helps these surfaces work with immune cells to manage everyday exposure to dust, microbes, and other outside triggers.
The IL1RL1 gene can also produce a soluble form, a free-floating version of the protein in body fluids. This form can bind IL-33 before it reaches cells, helping keep signaling more controlled.
What is a variant?
A genetic variant is a slight difference in the DNA sequence of a gene. These differences are common and help account for normal variation among people, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the IL1RL1 gene can change how much receptor is made, how stable it is, and whether it reaches the cell surface or is released in a soluble form. Research on how IL1RL1 gene variants affect immune signaling shows that some changes subtly shift signaling strength, while more disruptive variants can markedly reduce binding or create a shortened protein. This severity range can lead to milder or stronger effects on cell to cell signaling.
How variants are linked to conditions
Variants in the IL1RL1 gene are most consistently linked to asthma, especially allergic asthma, and to higher eosinophil levels, a blood finding often seen with allergy and airway inflammation. Studies also associate the IL1RL1 gene with atopic dermatitis and allergic rhinitis. These IL1RL1 gene variants linked to asthma and allergy risk may shift risk modestly and do not by themselves determine whether someone develops disease.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common across the general population. Most have no direct impact on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, however, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For IL1RL1, some gene changes are linked with a higher tendency toward asthma and other allergic conditions, but they do not decide your health on their own. Risk can also be shaped by things like family history, tobacco smoke, air pollution, and ongoing allergen exposure.
Inheritance of IL1RL1 variants
There is not yet a broadly confirmed single-gene inheritance pattern for IL1RL1-related health effects, because IL1RL1 gene variants are mainly studied as risk factors for traits such as asthma and allergic inflammation rather than as a clear inherited syndrome. In families, how IL1RL1 gene variants are inherited follows the usual pattern for genes on the numbered chromosomes: you inherit one copy from each parent. The IL1RL1 gene is on chromosome 2, which is an autosome, so these variants are not passed in an X-linked or Y-linked pattern.
What does my IL1RL1 result mean for my family?
There is not yet a broadly confirmed family inheritance pattern tied to a specific IL1RL1-related condition. A change in IL1RL1 is usually understood as one factor that may influence risk, rather than a finding that clearly predicts the same result or condition in relatives.
Genetic information
Genetic testing
How you find out about variants
IL1RL1 genetic testing looks for changes in the IL1RL1 gene using a blood sample, saliva, or a cheek swab. Most labs read the gene's code to check whether a specific variant is present, and the result can help clarify inherited risk but usually does not confirm a diagnosis by itself.
When should I consider getting a genetic test?
There is not yet a broadly established IL1RL1-specific reason for genetic testing in routine care. Decisions about testing are usually based on your symptoms, personal health history, and family history, ideally with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic findings can offer useful insight, but how much they reveal varies by the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can provide a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, transport, or respond to a drug differently. These inherited differences are common and can influence how strongly a medicine works or how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way someone responds to medicines. It focuses on gene-drug patterns to clarify why the same treatment may work differently in different people. For many medicines, genes can influence how strong a drug’s effects are or how the body handles it. This information can support treatment choices that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the IL1RL1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or treatment response are best discussed with your doctor. Medical advice is especially important if symptoms are changing, treatment is not helping as expected, or side effects are becoming hard to manage.
History
The IL1RL1 gene first drew attention in the late 1980s, when researchers identified a related molecule called ST2 in studies of cell growth. At that stage, its role was unclear, and it was mainly a laboratory finding rather than a gene with obvious clinical importance. Over time, scientists’ understanding of the gene’s function has changed. In the 1990s and early 2000s, work in immunology connected the IL1RL1 gene to signaling pathways involved in allergy, asthma, and inflammation. Later, interest widened again when blood tests measuring the soluble ST2 form became useful in heart failure research and clinical care. These historical steps shaped today’s understanding of IL1RL1 as a gene with relevance across both immune and heart medicine.